Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Trading 10-15 10:58:23 EDT

0.7656

-0.0218

-2.77%

High0.7792	Low0.7650	Vol29.67K
Open0.7700	D1 Closing0.7874	Amplitude1.80%
Mkt Cap3.42M	Tradable Cap3.35M	Total Shares4.47M
T/O22.80K	T/O Rate0.68%	Tradable Shares4.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":0.7656,"timestamp":1792076297834,"preClose":0.7874,"halted":0,"volume":29670,"delay":0,"changeRate":-0.027686055372110798,"floatShares":4377183,"shares":4468100,"eps":-6.647665,"marketStatus":"Trading","change":-0.0218,"latestTime":"10-15 10:58:23 EDT","open":0.77,"high":0.7792,"low":0.765,"amount":22798.3737039,"amplitude":0.018034,"askPrice":0.81,"askSize":245,"bidPrice":0.7655,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":-6.647665,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792094400000},"marketStatusCode":2,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":0.7874,"preHourTrading":{"tag":"盘前","latestPrice":0.769,"preClose":0.7874,"latestTime":"09:28 EDT","volume":6173,"amount":4740.0047184000005,"timestamp":1792070886125,"change":-0.0184,"changeRate":-0.023368,"amplitude":0.040767},"postHourTrading":{"tag":"盘后","latestPrice":0.7792,"preClose":0.7874,"latestTime":"19:33 EDT","volume":6295,"amount":4860.7998,"timestamp":1792020814090,"change":-0.0082,"changeRate":-0.010414,"amplitude":0.01143},"volumeRatio":0.873269},"requestUrl":"/m/hq/s/BJDX/tweets","defaultTab":"tweets","newsList":[{"id":"2675335722","title":"Bluejay Diagnostics Expands Symphony IL-6 Manufacturing Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2675335722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675335722?lang=en_us&edition=fundamental","pubTime":"2026-10-13 21:29","pubTimestamp":1791898168,"startTime":"0","endTime":"0","summary":"An announcement from Bluejay Diagnostics ( ($BJDX) ) is now available. On October 13, 2026, Bluejay Diagnostics announced it had completed the esta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-symphony-il-6-manufacturing-capabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-symphony-il-6-manufacturing-capabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675353481","title":"Bluejay Diagnostics Completes Symphony Cartridge Manufacturing Site, Bolstering Supply-Chain Resilience","url":"https://stock-news.laohu8.com/highlight/detail?id=2675353481","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675353481?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:31","pubTimestamp":1791887519,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics completes Symphony cartridge manufacturing site, bolstering supply-chain resilienceBluejay Diagnostics completed establishment of a Symphony cartridge manufacturing site, meeting a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL5gRP21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051023","title":"Bluejay Unveils SYMON-II Baseline Data for Symphony Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051023?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:34","pubTimestamp":1791293678,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) just unveiled an announcement. On October 6, 2026, Bluejay Diagnostics reported baseline clinical characteristics f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-unveils-symon-ii-baseline-data-for-symphony-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-unveils-symon-ii-baseline-data-for-symphony-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673582070","title":"Bluejay Diagnostics Details SYMON-II Dataset for IL-6 Sepsis Mortality Risk Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673582070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673582070?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:30","pubTimestamp":1791282618,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics details SYMON-II dataset for IL-6 sepsis mortality risk evaluationBluejay Diagnostics released baseline data from its SYMON-II clinical validation study evaluating IL-6 for 28-day ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLbLMYxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370136","title":"Bluejay Diagnostics expands federal access via Lovell partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:19","pubTimestamp":1788902399,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has shared an update. On September 1, 2026, Bluejay Diagnostics entered a distribution, co-marketing and strategic ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-federal-access-via-lovell-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-federal-access-via-lovell-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324104","title":"Bluejay Diagnostics and Lovell Government partner to access federal healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324104?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:35","pubTimestamp":1788863707,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (BJDX) and Lovell Government Services, a Service-Disabled Veteran-Owned Company specializing in federal healthcare distribution...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-and-lovell-government-partner-to-access-federal-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-and-lovell-government-partner-to-access-federal-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4585","NOBL","TCAF","VHT","BK4588","BK4082","BK4550","IXJ","CGCV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324533","title":"Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324533","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324533?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:30","pubTimestamp":1788863400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA8M5H2K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659544111","title":"Bluejay Advances Symphony Platform, Strengthens Cash Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2659544111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659544111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:17","pubTimestamp":1786623474,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has provided an announcement. On August 13, 2026, Bluejay Diagnostics reported second-quarter 2026 results, highlig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659685153","title":"Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659685153","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659685153?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:17","pubTimestamp":1786616272,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61167382/bluejay-diagnostics-q2-eps-1-12-5-64-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158032","title":"Bluejay Diagnostics Says SYMON-II Pivotal Study Completes Enrollment of 750 Patients for Symphony IL-6 Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:04","pubTimestamp":1786615496,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 testBluejay Diagnostics reported Q2 2026 progress on its SYMON-II pivotal study for the investiga","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLhvCLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117158","title":"Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ Il-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117158?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUAB7ZFPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158166","title":"Press Release: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony(TM) IL-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158166","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158166?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"-- SYMON-II pivotal clinical study completes targeted enrollment of 750. -- Company advances toward planned 510 submission and commercialization. with US manufacturing contract signed to mitigate supply-chain risk. -- Company ends second quarter with approximately $9.6 million in cash","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4588","BK4099","BK4555","TM","BK4585","03160","BK4604","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900393","title":"Bluejay Net Loss Widens to $2.32 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900393","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900393?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:12","pubTimestamp":1786565570,"startTime":"0","endTime":"0","summary":"Bluejay net loss widens to $2.32 million in Q2 FY26Bluejay Diagnostics posted a net loss of USD 2.32 million for the quarter ended June 30, 2026, widening from USD 1.96 million.Operating loss widened ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9lps6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549520","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549520?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:26","pubTimestamp":1785929213,"startTime":"0","endTime":"0","summary":"C3is  stock was up more than 65% in Wednesday's premarket activity after closing Tuesday with a 21% decreaseBluejay Diagnostics  shares were 38% higher pre-bell, extending an over 5% rise in the previous session.Julong  stock was up 37% after a 12% loss at the prior close.Gran Tierra Energy  shares were 48% higher after the company agreed to sell its oil business in Colombia and Ecuador to French oil and natural gas exploration and production company Maurel & Prom for an enterprise value of $1.33 billion.Jin Medical International  stock was up more than 28% following the release of its fiscal H1 results.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4129","IXC","DRIP","DIG","JLHL","BK7095","GUSH","BK4021","USE","XOP","BK4082","BK4570","BJDX","DBC","DRLL","DUG","PXE","CISS","BK4213","ERX","WTIU","XES","DBE","IEO","BK4588","BK4585","FTXN","ZJYL","VDE","GTE","GTE.AU","PXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653799188","title":"Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799188?lang=en_us&edition=fundamental","pubTime":"2026-07-23 05:48","pubTimestamp":1784756919,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762673","title":"Bluejay Diagnostics Initial Beneficial Ownership Statement Names Bank of America as 10% Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653762673?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:30","pubTimestamp":1784741418,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% ownerBluejay Diagnostics Form 3 disclosed Bank of America entities as 10% owners, reporting beneficial ownership","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1qTtnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFNS","LU0149725797.USD","IYF","LU0130518102.USD","LU0314106906.USD","LU0053666078.USD","LU0203345920.USD","LU1668664300.SGD","IE0034235188.USD","IE00BFXG1179.USD","LU1201861249.SGD","UYG","LU1267930227.SGD","BAC","LU1883839398.USD","LU1718418525.SGD","IE00B1BXHZ80.USD","BJDX","LU0203347892.USD","LU1280957306.USD","LU2129689431.USD","BK4534","FTXO","IE0001KFT4U8.USD","LU1880398554.USD","IYG","LU0980610538.SGD","LU1791807156.HKD","VFH","LU0130103400.USD","FNCL","KBWB","LU0128525689.USD","LU2596442595.SGD","LU2129689605.HKD","IE00BZ1G4Q59.USD","BK4585","LU0234570918.USD","LU0683600562.USD","BK4588","BK4082","XLF","LU1880398471.USD","LU1894683264.USD","LU2129689514.USD","LU0256863902.USD","LU0070302665.USD","LU0130102774.USD","LU0320765646.SGD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927953","title":"Bluejay Diagnostics completes enrollment in SYMON-II study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927953?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:35","pubTimestamp":1784630118,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (BJDX) announced the successful completion of patient enrollment in its SYMON-II multicenter clinical validation study. The stu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653055276","title":"Bluejay Diagnostics Announces Symon-ii Sepsis Study Enrollment Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2653055276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653055276?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:32","pubTimestamp":1784629961,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics announces SYMON-II sepsis study enrollment completionBluejay Diagnostics posted a press release on SYMON-II, confirming completion of enrollment in its multicenter clinical validat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL2rVsHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","BK4082","IE00BN0W2T93.GBP","BK4588","LU2210150020.SGD","SG9999014005.SGD","BCDF","BK4585","BK4112","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","NDAQ","LU2210149790.SGD","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762202","title":"Bluejay Diagnostics - Preliminary Symon-ii Data Show 17% 28-day Mortality Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653762202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:30","pubTimestamp":1784629800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUABTRFJQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653276204","title":"Bluejay Diagnostics Announces Successful Completion of Enrollment in the Symon-ii Multicenter Clinical Validation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653276204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653276204?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:30","pubTimestamp":1784629800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUABTRFJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.028},{"period":"1month","weight":-0.0738},{"period":"3month","weight":-0.3943},{"period":"6month","weight":-0.6063},{"period":"1year","weight":-0.9438},{"period":"ytd","weight":-0.705}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.09176},{"month":2,"riseRate":0.4,"avgChangeRate":-0.020494},{"month":3,"riseRate":0.4,"avgChangeRate":-0.104322},{"month":4,"riseRate":0.2,"avgChangeRate":-0.223757},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039698},{"month":6,"riseRate":0.4,"avgChangeRate":-0.217872},{"month":7,"riseRate":0.4,"avgChangeRate":-0.088216},{"month":8,"riseRate":0.2,"avgChangeRate":-0.172986},{"month":9,"riseRate":0.2,"avgChangeRate":-0.144886},{"month":10,"riseRate":0.4,"avgChangeRate":-0.047981},{"month":11,"riseRate":0,"avgChangeRate":-0.194266},{"month":12,"riseRate":0.2,"avgChangeRate":-0.253394}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}